Feihe Ma
Overview
Explore the profile of Feihe Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
155
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu M, Chen J, Wang S, Xu L, Wu X, Yu J, et al.
ACS Macro Lett
. 2025 Feb;
:250-257.
PMID: 39932169
Autophagosome-tethering compounds (ATTECs) represent an emerging targeted protein degradation (TPD) technology that directly draws intracellular proteins of interest (POIs) into autolysosomes. Although ATTECs are currently dominated by small molecules, the...
2.
Wang S, Wu X, Ren L, Pei X, Fang H, Lv P, et al.
Langmuir
. 2025 Jan;
41(4):2364-2372.
PMID: 39834166
Adsorbents with high selectivity and adsorption capacity are of significant interest for the removal of dye pollutants. Herein, we report a facile low-temperature solvothermal synthesis of clew-like CuO/CuO microspheres by...
3.
Wu X, Zhang Y, Song S, Liu S, Ma F, Ma R, et al.
Biomater Sci
. 2024 Oct;
12(22):5742-5752.
PMID: 39382287
PEGylation is a promising strategy for modulating the physicochemical properties and improving the therapeutic efficacy of protein drugs. However, the application of multi-PEGylation frequently results in diminished protein activity. A...
4.
Zhang F, Wang S, Yang S, Ma F, Gao H
Biomater Sci
. 2024 Mar;
12(8):1965-1980.
PMID: 38454904
Many studies suggest that tumor microbiome closely relates to the oncogenesis and anti-tumor responses in multiple cancer types (, colorectal cancer (CRC), breast cancer, lung cancer and pancreatic cancer), thereby...
5.
Zhang Y, Ma F, Chen J, Chen Y, Xu L, Li A, et al.
Adv Mater
. 2024 Feb;
36(19):e2309927.
PMID: 38387609
Cytokines are powerful in cancer immunotherapy, however, their therapeutic potential is limited by the severe systemic toxicity. Here a potent strategy to reduce the toxicity of systemic cytokine therapy by...
6.
Yan X, Xin Y, Yu Y, Li X, Li B, Elsabahy M, et al.
Small Methods
. 2023 Nov;
8(3):e2301309.
PMID: 38018349
Fusobacterium nucleatum (Fn) existing in the community of colorectal cancer (CRC) promotes CRC progression and causes chemotherapy resistance. Despite great efforts that have been made to overcome Fn-induced chemotherapy resistance...
7.
Yang M, Zhang Y, Deng F, Wu X, Chen Y, Ma F, et al.
Mater Horiz
. 2023 Oct;
10(12):5547-5554.
PMID: 37843027
Regulating protein folding including assisting folding, preventing misfolding and aggregation, and facilitating refolding of proteins are of significant importance for retaining protein's biological activities. Here, we report a mixed shell...
8.
Ou H, Huang F, Shen B, Gao Z, Ma F, Samanta D
Front Chem
. 2023 Jun;
11:1216173.
PMID: 37260538
No abstract available.
9.
Li X, Ma Y, Xin Y, Ma F, Gao H
ACS Appl Mater Interfaces
. 2023 Mar;
PMID: 36916659
() has long been found to be related to colorectal cancer (CRC), which could promote colorectal tumor progression and cause cancer resistance to chemotherapy. Great efforts have been made to...
10.
Zhang Y, Chen J, Shi L, Ma F
Mater Horiz
. 2022 Dec;
10(2):361-392.
PMID: 36541078
Therapeutic cancer vaccines, which are designed to amplify tumor-specific T cell responses, have been envisioned as one of the most powerful tools for effective cancer immunotherapy. However, increasing the potency,...